Figure 2.

Risk of not achieving minimal disease activity (MDA) at 12-month follow-up according to the presence of HS and/or CPs. 95%CI, 95% confidence interval; CPs, presence of carotid plaques (carotid intima-media thickness > 1.3 mm); HR, hazard ratio; HS, hepatic steatosis; MDA, minimal disease activity.

Di Minno et al. Arthritis Research & Therapy 2012 14:R211   doi:10.1186/ar4049
Download authors' original image